Showing results (21-30 of 219) with videos related to
Sort By:
Pageof 22
Hepatology International|December 9, 2016
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapyRebecca Lee, Shyam Kottilil, Eleanor WilsonHepatology International|March 20, 2015
Sofosbuvir for treatment of chronic hepatitis CSarah Kattakuzhy, Rachel Levy, Shyam KottililInfectious Agents and Cancer|May 26, 2016
Systemic manifestations of hepatitis C infectionLydia Tang, Lauren Marcell, Shyam KottililCells|June 2, 2021
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Arshi Khanam, Paul G Saleeb, Shyam KottililSouthern Medical Journal|August 13, 2003
Intracerebral tuberculoma misdiagnosed as neurosarcoidosisKaroll Cortez, Shyam Kottilil, Leonard A MermelNature Reviews. Immunology|October 22, 2005
NK cells in HIV infection: paradigm for protection or targets for ambushAnthony S Fauci, Domenico Mavilio, Shyam KottililAIDS Reviews|December 14, 2019
Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?Niyati Jakharia, Shyam Kottilil, Joel V ChuaInternational Journal of Molecular Sciences|June 2, 2021
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionArshi Khanam, Joel V Chua, Shyam KottililJournal of Hepatology|June 8, 2019
A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)Eleanor Wilson, Emily Covert, Jennifer Hoffmann, et al.The Indian Journal of Medical Research|April 9, 2005
Hepatitis B & hepatitis C in HIV-infectionShyam Kottilil, Julia O Jackson, Michael A PolisPageof 22